Neumora Therapeutics
formerly NeumoraIPORedefining neuroscience drug development.
Public · Watertown, United States · Founded 2021 · $612.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 51–200
- Founded
- 2021
- Business Model
- B2B
- Website
- neumoratx.com
- Total Funding
- $612.0M
- Last Round
- $112.0M Series BOct 2022
- Rounds
- 2
- Type
- Public
About
Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company founded in 2021 to confront the global brain disease crisis through precision medicine. The company develops novel therapies targeting unproven mechanisms of action for neuropsychiatric and neurodegenerative disorders, pairing each drug candidate with a biomarker strategy to identify the right patients. Its pipeline includes treatments for depression, Alzheimer's agitation, and other CNS diseases.
Summary
Neumora Therapeutics is a Biotech company based in Watertown, United States, founded in 2021. It has raised $612.0M in total across 2 rounds, most recently a $112.0M Series B round in Oct 2022. Investors include ARCH Venture Partners, Altitude Life Science Ventures and Amgen.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2023
Sign up to see all 3 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
.png)
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neumora-therapeutics"><img src="https://indexed.vc/api/badge/company/neumora-therapeutics" alt="Neumora Therapeutics on Indexed.vc" width="260" height="76" /></a>